luminespib   Click here for help

GtoPdb Ligand ID: 9261

Synonyms: AUY922 | NVP-AUY922
PDB Ligand
Compound class: Synthetic organic
Comment: Luminespib (NVP-AUY922) is an intravenous HSP90 inhibitor with the potential to target a range of cancers. Discovered during a research collaboration with Novartis, Vernalis is now looking to partner the programme. We have drawn the structure as depicted in its INN record. Other chemistry resources show alternative tautomers. For example, PubChem CID 10096043 matches on CAS registry number, but is a structural tautomer.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 108.06
Molecular weight 465.23
XLogP 4.03
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCNC(=O)c1noc(c1c1ccc(cc1)CN1CCOCC1)c1cc(C(C)C)c(cc1O)O
Isomeric SMILES CCNC(=O)c1noc(c1c1ccc(cc1)CN1CCOCC1)c1cc(C(C)C)c(cc1O)O
InChI InChI=1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,30-31H,4,9-12,15H2,1-3H3,(H,27,32)
InChI Key NDAZATDQFDPQBD-UHFFFAOYSA-N
Bioactivity Comments
NVP-AUY922 efficiently induced apoptosis in 32Dp210 (IC50 =10 nM) and T315I or E255K cell lines with IC50 around 20-50 nM. Bcr-Abl and Jak2 form high MW complexes with HSP90 in CML cells. Inhibition of HSP90 by NVP-AUY922 disrupted the structure of these complexes, leading to Bcr-Abl degradation, inhibiting proliferation and inducing apoptosis [3]. Thus, inhibition of HSP90 can inhibit not only imatinib-sensitive CML cells but also imatinib-resistant CML cells. The reference here looks at the in vitro cross-reactivity between HSP90 paralogues [1]. In another study this inhibitor also significantly reduced the cytotoxicity of NK cells by decreasing viability, inducing apoptosis and down-regulating the expression of cytokines and functional receptors, suggesting a potential immunosuppressant strategy [2].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
heat shock protein 90 alpha family class B member 1 Hs Inhibitor Inhibition 8.7 pIC50 -
pIC50 8.7 (IC50 2x10-9 M)
TNF receptor associated protein 1 Hs Inhibitor Inhibition 7.8 pIC50 -
pIC50 7.8 (IC50 1.6x10-8 M)